Other OTC - Delayed Quote USD

EV Biologics, Inc. (YECO)

0.6021 0.0000 (0.00%)
At close: April 19 at 11:36 AM EDT

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Daniel S. McKinney Founder, Chairman & CEO -- -- 1962
Mr. Monte Fisher Chief Financial Officer -- -- --
Mr. William Bossung Corporate Finance Director & Corporate Secretary -- -- --

EV Biologics, Inc.

1621 Central Avenue
Cheyenne, WY 82001
United States
206-734-4738 https://www.evbiologics.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
284

Description

EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics, Inc. in August 2020. EV Biologics, Inc. was incorporated in 2011 and is headquartered in Cheyenne, Wyoming.

Corporate Governance

EV Biologics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Nov 09, 2017
    Dividend Date

Upcoming Events

Related Tickers

KROS Keros Therapeutics, Inc.
56.24
+1.90%
 
PULM Pulmatrix, Inc.
2.0201
-3.34%
 
XBIO Xenetic Biosciences, Inc.
3.8400
-0.26%
 
PTCT PTC Therapeutics, Inc.
25.21
-0.79%
 
NBY NovaBay Pharmaceuticals, Inc.
0.0773
+0.39%
 
ANVS Annovis Bio, Inc.
12.74
+7.24%
 
REGN Regeneron Pharmaceuticals, Inc.
906.54
-0.09%
 
MNMD Mind Medicine (MindMed) Inc.
8.46
-4.62%
 
VNDA Vanda Pharmaceuticals Inc.
4.5600
-1.51%
 
VRTX Vertex Pharmaceuticals Incorporated
400.76
-1.02%